IPHA
Innate Pharma
IPHA
IPHA
16 hedge funds and large institutions have $6.52M invested in Innate Pharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$1.81M |
2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
$839K |
3 |
Optiver Holding
Amsterdam,
Netherlands
|
$1.03M |
4 |
AA
ALPS Advisors
Denver,
Colorado
|
$429K |
5 |
Bank of America
Charlotte,
North Carolina
|
$1.13M |